NewDay Veterinary Care Offering OncoK9 Cancer Screening Test for Dogs | PetDx®
OncoK9®
Now Available at
NewDay Veterinary Care

Screen Your Dog for Cancer With a Simple Blood Draw

OncoK9® is a blood test that screens dogs for cancer before they show any clinical signs of disease. It uses the same DNA technology as the most advanced cancer screening in people. This is a new day in preventive care for our dogs!

Find out the recommended age to start screening your dog for cancer using the OncoK9 Cancer SAFE Tool and receive a $150 gift card with the purchase of OncoK9.

Find Your Dog's Screening Age Schedule OncoK9 @ NewDay
 

FEATURED IN:

Media Coverage - AKC.tv Media Coverage - Wired Media Coverage - Yahoo! Media Coverage - The Telegraph Media Coverage - Scientific American Media Coverage - Newsweek Peer-Reviewed Publication - PLOS ONE Media Coverage - El Pais Media Coverage - The Scientist Media Coverage - Cheddar Media Coverage - dvm360 Media Coverage - Nasdaq Media Coverage - CNET Media Coverage - iHeart Media Coverage - Pet Age Media Coverage - AKC.tv Media Coverage - Wired Media Coverage - Yahoo! Media Coverage - The Telegraph Media Coverage - Scientific American Media Coverage - Newsweek Peer-Reviewed Publication - PLOS ONE Media Coverage - El Pais Media Coverage - The Scientist Media Coverage - Cheddar Media Coverage - dvm360 Media Coverage - Nasdaq Media Coverage - CNET Media Coverage - iHeart Media Coverage - Pet Age Media Coverage - AKC.tv Media Coverage - Wired Media Coverage - Yahoo! Media Coverage - The Telegraph Media Coverage - Scientific American Media Coverage - Newsweek Peer-Reviewed Publication - PLOS ONE Media Coverage - El Pais Media Coverage - The Scientist Media Coverage - Cheddar Media Coverage - dvm360 Media Coverage - Nasdaq Media Coverage - CNET Media Coverage - iHeart Media Coverage - Pet Age

Use the OncoK9 Cancer SAFE Tool

Find out the recommended age to start screening your dog for cancer.

Open OncoK9 Cancer SAFE Tool

Explore the OncoK9 Science

Review summaries of the peer-reviewed publications PetDx authored to introduce liquid biopsy technology to veterinary medicine and clinically validate OncoK9 in the largest canine cancer study.

View Introduction to Liquid Biopsy
View CANDiD Study Summary

Discover the OncoK9 Test

Learn more about OncoK9 and share information with others.

Download OnocoK9 PDF

What is Cancer Screening?

Just like in people, cancer screening should be an important part of preventive care in dogs; the goal is to look for cancer when your pet is feeling well, before they start to show any clinical signs.

During wellness visits, your veterinarian may look for early signs of cancer in your dog by performing a thorough physical exam and asking you about any concerning observations. Your veterinarian may also perform routine blood and imaging tests, and may recommend OncoK9 - a new blood test that could detect cancer before your dog shows any clinical signs.

Why is Early Cancer Detection Important?

Early detection and treatment are the best ways to manage cancer in pets... cancer is frequently treatable and early diagnosis will aid your veterinarian in delivering the best care possible.

American Veterinary Medical Association

AKC.tv : Ask the Expert – Canine Cancer

OncoK9
Dr. Andi Flory
Chief Medical Officer and Co-Founder of PetDx

Dr. Flory joins Mike Janela to answer viewer questions about canine cancer and how a new liquid biopsy test enables veterinarians to detect cancer in dogs with a simple blood draw.

What is OncoK9?

The OncoK9 liquid biopsy test uses a simple blood draw to detect abnormal DNA released into circulation by cancer cells.

Early detection

Early
Detection

OncoK9 may help detect cancer early, when your dog still looks healthy and has the best chance of defeating the disease.

Simple blood draw

Simple
Blood Draw

OncoK9 requires only a simple blood draw. The sample collection can take place during a routine visit to the clinic with no fasting beforehand.

Multi-cancer coverage

Multi-Cancer
Coverage

OncoK9 can detect 30 different types of cancer, including 8 of the most common cancers in dogs.

Cutting-edge technology

Cutting-Edge
Technology

OncoK9 uses state-of-the-art next-generation sequencing (NGS) technology to detect changes in DNA that are indicative of cancer.

Clinically validated

Clinically
Validated

OncoK9 was validated with the largest clinical study ever performed in veterinary cancer diagnostics.

Top